Evergreen Health Solutions Ltd
Private Limited Company · Manchester
ActiveUnited KingdomIncorporated 2015Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2020-06-30
IXBRL · 182 source facts · 25 selected values
Not assessedlegacy record
Accounts to 2020-06-30
IXBRL · 182 source facts · 25 selected values
Not assessed
legacy record
- Reporting period
- 2019-07-01 to 2020-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 113
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0090_09484935_20200630
- Source archive
- Accounts_Monthly_Data-May2021.zip
Accounts to 2019-06-30
IXBRL · 175 source facts · 25 selected values
Not assessedlegacy record
Accounts to 2019-06-30
IXBRL · 175 source facts · 25 selected values
Not assessed
legacy record
- Reporting period
- 2018-07-01 to 2019-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 102
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2018-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0076_09484935_20190630
- Source archive
- Accounts_Monthly_Data-March2020.zip
Accounts to 2018-06-30
IXBRL · 143 source facts · 26 selected values
Not assessedlegacy record
Accounts to 2018-06-30
IXBRL · 143 source facts · 26 selected values
Not assessed
legacy record
- Reporting period
- 2017-07-01 to 2018-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 75
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0064_09484935_20180630
- Source archive
- Accounts_Monthly_Data-March2019.zip
Accounts to 2017-06-30
IXBRL · 94 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2017-06-30
IXBRL · 94 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2016-04-01 to 2017-06-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 50
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0052_09484935_20170630
- Source archive
- Accounts_Monthly_Data-March2018.zip
Accounts to 2016-03-31
IXBRL · 51 source facts · 9 selected values
Not assessedlegacy record
Accounts to 2016-03-31
IXBRL · 51 source facts · 9 selected values
Not assessed
legacy record
- Reporting period
- 2015-03-12 to 2016-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 18
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0037_09484935_20160331
- Source archive
- Accounts_Monthly_Data-December2016.zip
Registered details
09484935- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2015-03-12
- Jurisdiction
- —
- Registered office
- EVERGREEN HOUSE, THE EDGE, MANCHESTER, M3 5NA, UNITED KINGDOM
Classification
1 SIC codes23006
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
2 matched grantsUsing NLP to Target Patient Led and Scalable Primary Care InteractionsLead
Innovate UK · Collaborative R&D · 2023-04-01 – 2026-03-31
£439,521
awarded
Predicting kidney and liver damage in cancer patients receiving chemotherapyLeadInnovate UK · Collaborative R&D · 2022-08-01 – 2024-10-31 · with 3 other participants£268,189awarded
Predicting kidney and liver damage in cancer patients receiving chemotherapyLead
Innovate UK · Collaborative R&D · 2022-08-01 – 2024-10-31 · with 3 other participants
£268,189
awarded
Evergreen Health Solutions Ltdlead£268,189
Durham University£174,613
Uclh NHS Foundation Trust£127,574